Resources

The following materials are provided by Aclaris Therapeutics.

Patient brochure

This brochure will help your patients understand SK as a disease state, as well as the efficacy and safety of ESKATA.

Download the brochure

   

Frequently asked questions (FAQ)

ESKATA can be administered by physician or nonphysician healthcare providers.
Certification is not required prior to purchase or use, but it is recommended that healthcare providers review the application technique in the ESKATA Prescribing Information.
Application time will vary depending on the number of lesions treated with each applicator.
Prior to application of ESKATA, clean the seborrheic keratoses to be treated using an alcohol wipe. When treating seborrheic keratoses on the face, take appropriate actions to ensure that ESKATA will not come into contact with the eyes.
ESKATA does not require refrigeration or any other special storage. ESKATA needs to be stored at room temperature (68-77°F)
ESKATA has a shelf life of 2 years at room temperature (68-77°F). Once the applicator is activated, the product will be stable for 4 hours.

Order ESKATA now

INDICATIONS AND USAGE

ESKATA™ (hydrogen peroxide) topical solution, 40% (w/w) is indicated for the treatment of seborrheic keratoses that are raised.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Do not apply ESKATA to the eyes or mucous membranes. Avoid treating seborrheic keratoses within the orbital rim. Direct contact with the eye can cause corneal injury (erosion, ulceration, perforation, and scarring), chemical conjunctivitis, eyelid edema, severe eye pain or permanent eye injury, including blindness. If accidental exposure occurs, flush with water for 15 to 30 minutes, initiate monitoring and further evaluation as appropriate.

Skin reactions occurred in the treatment area after application of ESKATA. Severe local skin reactions included erosion, ulceration, vesiculation and scarring. Do not retreat until the skin has recovered from any reaction caused by the previous treatment.

MOST COMMON ADVERSE REACTIONS

The most common adverse reactions include erythema (99%), stinging (97%), edema (91%), scaling (90%), crusting (81%), and pruritus (58%).

CONTRAINDICATIONS

None.

DOSAGE AND ADMINISTRATION

ESKATA is to be administered by a healthcare provider. For topical use only. Not for oral, ophthalmic, or intravaginal use. Not for open or infected seborrheic keratoses.

Please see accompanying full Prescribing Information for ESKATA (hydrogen peroxide) topical solution, 40% (w/w).